Skip to content
Screener

Keros Therapeutics KROS Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$14.3MBeat by $10.6M
EPS-$0.18Beat by $0.93
Revenue estimate$3.7M
EPS estimate-$1.11

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$14.8M
EPS estimate-$0.96

FAQ

When did Keros Therapeutics report Q3 2025 earnings?
Keros Therapeutics (KROS) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Keros Therapeutics's Q3 2025 revenue and EPS?
Keros Therapeutics reported revenue of $14.3M and eps of $-0.18 for Q3 2025.
Did Keros Therapeutics beat estimates in Q3 2025?
Revenue beat the consensus estimate of $3.7M by $10.6M. EPS beat the consensus estimate of $-1.11 by $0.93.
How did Keros Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3575.8% from $388.0K a year earlier and eps grew 87.2% from $-1.41.
Where can I find Keros Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001664710-25-000086) and the 10-Q periodic report (0001664710-25-000089) directly on SEC EDGAR. The filing index links above go to sec.gov.